Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on a pneumococcal vaccine booster in healthy children aged 12-18 months previously primed with the same vaccines; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal
• Streptococcal Infections

Drugs mentioned

• GlaxoSmithKline pneumococcal vaccine booster

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2019-01-14